glycyl-arginyl-glycyl-aspartyl-seryl-proline has been researched along with Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Downey, L; Guo, H; Kuo, PC; Marroquin, CE | 1 |
1 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-seryl-proline and Leukemia
| Article | Year |
|---|---|
Osteopontin increases CD44 expression and cell adhesion in RAW 264.7 murine leukemia cells.
Topics: Animals; Anisomycin; Cell Adhesion; Cell Line, Tumor; Hyaluronan Receptors; Leukemia; Mice; Neoplasms, Experimental; Oligopeptides; Osteopontin; RNA, Messenger; Sialoglycoproteins | 2004 |